Firefly Neuroscience (AIFF) Profit After Tax Growth (3y) (2013 - 2026)
Powered by 
Analysis
Firefly Neuroscience (AIFF) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 9.79% |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | -7.28% |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -59.11% |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | 23.35% |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | -20.42% |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | - |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 20.01% |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | -85.15% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -85.15% |
| Mar 31, 2026 | -14.08% |
| Dec 31, 2025 | -28.62% |
| Sep 30, 2025 | 17.50% |
| Jun 30, 2025 | -6.31% |
| Mar 31, 2025 | -83.92% |
| Dec 31, 2024 | -49.30% |
| Sep 30, 2024 | -311.88% |
| Jun 30, 2024 | -285.49% |
| Mar 31, 2024 | -83.14% |
| Dec 31, 2023 | -70.94% |
| Sep 30, 2023 | -71.31% |
| Jun 30, 2023 | 147.63% |
| Mar 31, 2023 | -120.26% |
| Dec 31, 2022 | -308.56% |
| Sep 30, 2022 | -197.11% |
| Jun 30, 2022 | -94.10% |
| Mar 31, 2022 | -121.65% |
| Dec 31, 2021 | -332.84% |
| Sep 30, 2021 | -75.61% |